Study location	United Kingdom, Bradford
Type	Master courses, full-time
Nominal duration	1 year
Study language	English
Awards	MSc

Tuition fee	To be confirmed

Entry qualification

Undergraduate diploma (or higher) 2:2 or above in a science subject. Applications are welcome from candidates with non-standard qualifications, who have significant relevant experience. The entry qualification documents are accepted in the following languages: English. Often you can get a suitable transcript from your school. If this is not the case, you will need official translations along with verified copies of the original. Upload documents in original language and translations Vykdamas į pasirinktą universitetą, privalai pasiimti patvirtintas dokumentų kopijas, kurių universitetas reikalavo stojimo metu.

Language requirements	English Accepted proof of proficiency: FCE or CAE, IELTS 6+, TOEFL 79+ or CAE result B2 With sub-test least 5.5 or pass an equivalent (CAE)

Other requirements	At least 2 reference(s) must be provided. A motivation letter must be added to your application.

More information	Expenses, accommodation, working etc. bradford.ac.uk/..duate/cancer-pharmacology

Overview

Based upon a greater understanding of the molecular aspects of cancer, new opportunities for therapeutic intervention have emerged that are effectively ‘target orientated’. These new therapeutics are quite distinct from the classical chemotherapeutic agents and they offer the prospect of truly selective cancer therapies that are tailored towards the individual patient’s tumour. This is an exciting time to be involved in cancer therapeutics and cancer pharmacology plays a key role in drug development. In both the laboratory and the clinic, cancer pharmacology has had to adapt to the changing face of drug development by establishing experimental models and target orientated approaches.

The programme is designed to provide you with a ‘state-of-the-art’ course in modern cancer pharmacology that meets the demand of employers and an expert view of the available cancer medicines and the development of new cancer therapies.

Programme structure

Modules: All Modules are Core

Semester 1 (60 Credits – 4 Modules):

Critical Appraisal of a Current Topic in Cancer Biology (20 Credits split across both Semesters, 10 Credits per Semester)
Molecular Basis of Cancer and Cancer Therapy (20 Credits)
Preclinical Models for Drug Evaluation (20 Credits)
Research and Analytical Methods (20 Credits split across both Semesters, 10 Credits per Semester)
Semester 2 (60 Credits – 4 Modules):

Cancer Pharmacology (20 Credits)
Critical Appraisal of a Current Topic in in Cancer Biology (20 Credits split across both Semesters, 10 Credits per Semester)
Experimental Design (20 Credits)
Research and Analytical Methods (20 Credits split across both Semesters, 10 Credits per Semester)
End of Semester 2 onwards (60 Credits – 1 Module);

Research Project in Cancer Pharmacology (60 Credits)

Career opportunities

Many students go on to study for PhDs either at Bradford or elsewhere. Recent graduates are studying at Dundee, Newcastle and Glasgow universities.
Those in employment are in R&D and clinical research roles.